The recent funding round brings Naveris’ total capital raised to $51 million. The financing will be used to advance the commercialization of Naveris’ blood test tools for the early detection of cancers caused by human papillomavirus, according to the Sept. 19 Naveris news release.
The funding round was led by Gurnet Point Capital, with participation from TechU Ventures and the venture capital arm of the American Cancer Society, BrightEdge.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
